BRK.B vs GSK · rev $371.44B vs P/E 13, $103.31B cap
BRK.B (BRK.B) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
GSK does not have a complete income-statement cache yet.
BRK.B currently screens at market cap $0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BRK.B and GSK stock pages for the full models.
Not investment advice.